Government Settles False Claims Act Allegations Against Kansas Cancer Treatment Facility And Its Owner
The Hope Cancer Institute, based in Kansas City, Kansas, and its Director, Dr. Raj Sadasivan, will pay $2.9 million to resolve a lawsuit filed by three former employees of the under the qui tam provisions of the False Claims Act. The suit alleges that from 2007 to 2011, Sadasivan instructed the cancer treatment center to submit bills for dosages of the cancer drugs Rituxan, Avastin and Taxotere that were higher than the amounts of the drugs actually administered to patients. In doing so, the Hope Cancer Institute and Dr. Sadasivan submitted inflated claims to Medicare, Medicaid and the Federal Employee Health Benefits Program in violation of the False Claims Act.
For more information, please click here.